Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Arthritis and Rheumatism, Vol. 61, No. 6, 15.06.2009, p. 854-5; author reply 855-6.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids
T2 - comment on the article by Gonzalez-Juanatey et al
AU - Sandoo, Aamer
AU - Toms, Tracey
AU - Zanten, Jet Veldhuijzen van
AU - Carroll, Douglas
AU - Kitas, George
PY - 2009/6/15
Y1 - 2009/6/15
KW - Antibodies, Monoclonal
KW - Antibodies, Monoclonal, Murine-Derived
KW - Antirheumatic Agents
KW - Arthritis, Rheumatoid
KW - Blood Proteins
KW - Drug Therapy, Combination
KW - Glucocorticoids
KW - Humans
KW - Infusions, Intravenous
KW - Lipids
KW - Methylprednisolone
KW - Regional Blood Flow
KW - Rituximab
KW - Vasodilation
KW - Comment
KW - Letter
U2 - 10.1002/art.24582
DO - 10.1002/art.24582
M3 - Article
C2 - 19479694
VL - 61
SP - 854-5; author reply 855-6
JO - Arthritis and Rheumatism
JF - Arthritis and Rheumatism
SN - 0004-3591
IS - 6
ER -